A detailed history of Shelton Capital Management transactions in Novartis Ag stock. As of the latest transaction made, Shelton Capital Management holds 7,843 shares of NVS stock, worth $771,359. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,843
Previous 7,878 0.44%
Holding current value
$771,359
Previous $838,000 7.64%
% of portfolio
0.02%
Previous 0.02%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$106.13 - $120.89 $3,714 - $4,231
-35 Reduced 0.44%
7,843 $902,000
Q2 2024

Aug 13, 2024

SELL
$92.57 - $107.37 $19,254 - $22,332
-208 Reduced 2.57%
7,878 $838,000
Q1 2024

May 15, 2024

BUY
$95.27 - $108.47 $770,353 - $877,088
8,086 New
8,086 $782,000
Q4 2023

Feb 14, 2024

SELL
$92.27 - $101.54 $9,227 - $10,154
-100 Reduced 3.57%
2,700 $272,000
Q2 2023

Aug 10, 2023

SELL
$92.52 - $104.91 $4,626 - $5,245
-50 Reduced 1.75%
2,800 $282,000
Q1 2023

May 11, 2023

BUY
$80.03 - $92.81 $4,001 - $4,640
50 Added 1.79%
2,850 $262,000
Q4 2022

Feb 13, 2023

BUY
$75.55 - $92.52 $211,540 - $259,056
2,800 New
2,800 $254,000
Q3 2022

Nov 14, 2022

BUY
$74.61 - $87.26 $208,908 - $244,328
2,800 New
2,800 $213,000
Q2 2022

Aug 11, 2022

SELL
$80.52 - $93.75 $48,312 - $56,250
-600 Reduced 17.65%
2,800 $237,000
Q4 2020

Feb 16, 2021

BUY
$78.07 - $94.43 $31,227 - $37,772
400 Added 13.33%
3,400 $321,000
Q1 2020

May 13, 2020

SELL
$70.67 - $99.01 $3,533 - $4,950
-50 Reduced 1.64%
3,000 $247,000
Q2 2019

Aug 14, 2019

BUY
$75.4 - $92.8 $207,877 - $255,849
2,757 Added 940.96%
3,050 $278,000
Q1 2019

May 10, 2019

SELL
$75.32 - $86.15 $205,774 - $235,361
-2,732 Reduced 90.31%
293 $3.05 Million
Q3 2018

Nov 14, 2018

SELL
$66.94 - $77.43 $5,355 - $6,194
-80 Reduced 2.58%
3,025 $261,000
Q1 2018

May 15, 2018

BUY
$70.39 - $84.15 $218,560 - $261,285
3,105 New
3,105 $251,000
Q4 2017

Feb 06, 2018

SELL
$72.33 - $77.64 $943,544 - $1.01 Million
-13,045 Closed
0 $0
Q3 2017

Nov 14, 2017

SELL
$74.14 - $77.27 $22,242 - $23,181
-300 Reduced 2.25%
13,045 $1.12 Million
Q2 2017

Aug 14, 2017

SELL
N/A
-147 Reduced 1.09%
13,345 $1.11 Million
Q1 2017

Nov 28, 2017

SELL
N/A
-125 Reduced 0.92%
13,492 $1 Million
Q3 2016

Dec 06, 2017

BUY
N/A
13,617 New
13,617 $1.08 Million
Q3 2016

Dec 04, 2017

BUY
N/A
13,617
13,617 $992,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Shelton Capital Management Portfolio

Follow Shelton Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Shelton Capital Management with notifications on news.